← Enhanced Wellness
    GLP-1 Receptor Agonist

    Semaglutide
    Support Weight Loss Medication

    A groundbreaking GLP-1 receptor agonist that has revolutionized weight management — originally developed for type 2 diabetes, now the go-to choice for sustainable, medically-supervised weight loss.

    12–15%

    Average Weight Loss

    20%

    Reduced Cardiovascular Risk

    FDA

    Approved

    Weekly

    Injection Option

    Why Semaglutide Works

    Semaglutide works by mimicking a hormone called GLP-1 that targets areas of the brain involved in appetite regulation. It helps your body produce more insulin when needed, reduces glucagon secretion, and slows gastric emptying — so you feel full longer and eat less naturally.

    Mechanism of Action

    • Insulin Secretion: Stimulates glucose-dependent insulin release from pancreatic beta cells
    • Glucagon Suppression: Reduces glucagon secretion when glucose levels are elevated
    • Gastric Emptying: Slows gastric emptying, promoting satiety and reducing post-meal glucose spikes
    • Appetite Regulation: Acts on brain receptors to naturally reduce hunger and food noise

    "After struggling with weight for years, Semaglutide finally gave me the control I needed. I've lost 38 pounds and kept it off for over a year."

    — Michael R., Client

    What's Included at I.R.I.S.E.

    • Sustainable long-term weight loss — 12–15% average body weight reduction
    • Cardiovascular protection — reduces risk of major cardiovascular events by 20%
    • Multiple forms available — weekly injection or daily oral tablet
    • Clinically proven results backed by extensive research
    • Physician supervised through Dr. Crystal Broussard, MD (licensed in all 50 states)
    • Integrated with I.R.I.S.E. behavioral coaching for lasting lifestyle change

    Physician Supervised

    Available in all 50 states. Health screening required to determine eligibility. Dr. Crystal Broussard, MD (NPI 1588688576) oversees all medical aspects.